from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2887/-

LFCtreatmentdescriptionclass of inhibitor

0.946

Amikacinug/mL Amikacintranslation

0.922

Cap5-10ug/mL Capreomycintranslation

1.377

Rox10-50 ug/mL Roxithromycintranslation

0.740

SM2-5 ug/mL Streptomycintranslation

2.241

Tet5-10 ug/mL Tetracyclinetranslation

-0.280

Rif0.2-5ug/mL Rifampicintranscription

0.297

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.066

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.051

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.422

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.128

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.404

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.219

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.521

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.079

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.771

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.263

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.096

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.267

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.220

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.713

KCN5-20 ug/mL Potassium cyaniderespiration

-0.047

NaN30.2-2 mM Sodium aziderespiration

0.261

Nigericin50 uM Nigericinrespiration

-0.670

TRC10-150 ug/mL Triclosanrespiration

-0.132

TRZ10-25 ug/mL Thioridazinerespiration

3.833

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

1.211

menadione6-10 ug/mL Menadionerespiration

-0.460

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.058

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.314

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.783

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.229

NRP_1Non-replicating persistence stage 1dosRassociated

-0.364

Amp0.2mg/mL AmpicillincellWall

-0.366

Cephalexin20-100 ug/mL CephalexincellWall

0.076

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.278

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.949

EMB10-20 ug/mL EthambutolcellWall

0.159

Eta12-40 ug/mL EthionamidecellWall

0.620

INH0.2-0.4 ug/mL IsoniazidcellWall

1.022

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.003

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.792

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.416

BZA0.12 mg/mL BenzamidearomaticAmides

-0.426

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.307

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.031

H2O24 mM hydrogen peroxideDNAdamaging

0.544

Levo10 ug/mL LevofloxacinDNAdamaging

-0.168

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.276

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.141

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.082

UVUV-irradiationDNAdamaging

-0.550

ARP41-4 ug/mL Antitubercular compound ARP4?

0.068

Antimycin12.5-50 ug/mL Antimycin A?

-0.288

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.737

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.248

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.217

PA8240.2-2 ug/mL PA-824?

0.843

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.137

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.270

Verapamil50 uM Verapamil?

-0.209

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.549

methoxatin10-20 ug/mL Methoxatin?